The overall goal of this work was to provide information required for optimizing the use of CSC/CPCs for treating cardiovascular diseases and provide a deeper understanding of the mechanisms by which miRNAs regulate cardiac stem cell differentiation in Sca-1+CD31− and Sca-1+CD31+ cells. Here, PECAM1 is linked to cardiovascular disorder.